Hinova Pharmaceuticals Inc. (SHSE: 688302)
Health Care · Pharmaceuticals · CN
CN¥32.09
-3.75% today · -36.5% 1Y
Hinova Pharmaceuticals Inc. (SHSE: 688302) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $474.37M.
Over the last twelve months the share price has lost 36.5%, trading between 28.68 and 60.00.
Tweenvest scores Hinova Pharmaceuticals Inc. across four factors: quality 43/100, value 68/100. Its strongest factor is value.
688302 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $474.37M
- Revenue (TTM)
- $9.17M
- P/E
- —
- EPS
- -1.34
- Dividend yield
- —
- Beta (5Y)
- -0.07
- 52-week high
- CN¥60.00
- 52-week low
- CN¥28.68
- Avg volume (3M)
- —
- Shares outstanding
- 99.02M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zhejiang Haisen Pharmaceutical Co., Ltd.SZSE: 001367 | $488.63M | CN¥21.77 | -1.09% |
| Gujarat Themis Biosyn LimitedBSE: 506879 | $488.50M | Rs363.25 | -5.00% |
| Clarity Pharmaceuticals LtdASX: CU6 | $480.35M | AU$1.85 | -12.14% |
| Zhejiang East Asia Pharmaceutical Co., Ltd.SHSE: 605177 | $475.37M | CN¥28.29 | +16.61% |
| Zota Health Care LimitedNSEI: ZOTA | $473.82M | Rs1,324.10 | +4.44% |
| ScinoPharm Taiwan, Ltd.TWSE: 1789 | $472.34M | NT$19.10 | +2.69% |
| Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.SZSE: 300452 | $470.60M | CN¥13.55 | +2.19% |
| Shanghai Fudan Forward S&T Co., LtdSHSE: 600624 | $469.59M | CN¥4.63 | +0.43% |
Figures last refreshed Oct 11, 2026.